Singapore markets open in 8 hours
Straits Times Index
3,314.05 +0.57 (+0.02%) S&P 500
5,321.79 +18.52 (+0.35%) Dow
39,972.12 -31.47 (-0.08%) Nasdaq
16,821.90 +135.94 (+0.81%) Bitcoin USD
68,199.60 +1,532.62 (+2.30%) CMC Crypto 200
1,387.70 +33.28 (+2.46%)
NVO May 2024 175.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:22PM EDT. Market open.
Loading interactive chart…
- Benzinga
Genetic Profile Key To Novo Nordisk's Wegovy's Weight-Loss Effectiveness, Study Reveals
Researchers highlighted on Monday that certain genes may help identify patients with obesity who are most likely to respond strongly to Novo Nordisk A/S’s (NYSE:NVO) weight-loss drug Wegovy (semaglutide). The study, presented at the Digestive Disease Week meeting in Washington, found a 95% likelihood that patients with this genetic profile would be strong responders to the treatment. Related: Changing Frugal Eating Habits-How Novo Nordisk/Eli Lilly’s Weight Loss Drugs Reshaping Food Spending. Th
- Zacks
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.
- Zacks
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
© 2024 Yahoo. All rights reserved.